Clinemo
Clinemo
Clinical Insights
13 min read
June 21, 2026

COPD, Asthma, and Respiratory Disease OPD Management: A Guide for Indian Clinic Doctors

Evidence-based protocols for managing COPD, asthma, TB screening, and breathlessness in Indian OPD — including inhaler technique assessment, exacerbation management, and pulmonary referral criteria.

COPD management clinic Indiaasthma OPD treatment Indiabreathlessness diagnosis Indian doctorsTB screening clinic India
CF

Clinemo Editorial Team

Clinic Management Experts · India

Want to implement this in your clinic?

Clinemo covers everything in this guide — ABDM, GST billing, OPD management, lab, pharmacy. Book a free 30-minute demo.

Book Free Demo
37MIndians with asthma
55MIndians with COPD
2.8Mnew TB cases in India annually (27% of global burden)
70%of asthma patients have poor inhaler technique

Respiratory disease in India carries a unique burden: India has the world's highest COPD mortality, a massive asthma population, and 27% of the global tuberculosis burden. Every clinic doctor in India is, by necessity, a front-line respiratory physician.

Approach to Breathlessness in OPD

Breathlessness is never just "breathlessness" — the differential spans cardiac, respiratory, haematological, and metabolic causes. Structured assessment prevents missing dangerous diagnoses:

  • Onset: Acute (minutes) → think PE, pneumothorax, acute LVF, anaphylaxis. Subacute (days) → pneumonia, AECOPD, pleural effusion. Chronic/progressive → COPD, heart failure, ILD, anaemia
  • Position: Orthopnoea (worse lying flat) → heart failure. Platypnoea (worse sitting up) → hepatopulmonary syndrome
  • Associated symptoms: Wheeze → asthma/COPD. Cough + fever → infection. Chest pain → PE/pneumonia/pneumothorax. Haemoptysis → TB/malignancy/PE
  • Examination essentials: SpO₂ (every breathless patient), RR (most neglected vital sign), percussion (dull = effusion/consolidation; hyperresonant = pneumothorax), auscultation
🚨
SpO₂ <92% = immediate action required
SpO₂ <92% on room air is a medical emergency. Give supplemental oxygen, call 108, and prepare for transfer. Do not discharge a breathless patient without checking SpO₂. In COPD patients, target SpO₂ 88–92% (not 98–100%) — high-flow O₂ can suppress hypoxic drive and cause CO₂ retention.

Asthma: Diagnosis and Step-Up Therapy

Diagnosis

Asthma is a clinical diagnosis. Key features: episodic wheeze, breathlessness, chest tightness, cough (especially nocturnal) — variable and reversible. Confirm with spirometry if available: FEV1/FVC <0.7 with ≥12% and 200ml improvement post-bronchodilator.

In Indian children, be aware that GORD, rhinitis, and post-nasal drip are common asthma mimics. Treat comorbidities alongside asthma.

GINA 2024 Step-Up Therapy

1
Step 1: Symptoms ≤2 days/week, no night wakings
As-needed low-dose ICS-formoterol (Budesonide-Formoterol 200/6 mcg) used only when symptomatic. This replaces SABA monotherapy — GINA 2019+ no longer recommends SABA-only for any step.
2
Step 2: Symptoms >2 days/week or any night waking
Low-dose ICS daily (Budesonide 200mcg BD or Fluticasone 100mcg BD) + as-needed SABA. Alternatively: low-dose ICS-formoterol as both maintenance and reliever (MART regimen).
3
Step 3: Not controlled on Step 2
Medium-dose ICS + LABA (Budesonide 400mcg + Formoterol BD). Add montelukast if allergic rhinitis is comorbid. Review inhaler technique and adherence before stepping up.
4
Step 4–5: Severe/uncontrolled asthma
High-dose ICS-LABA + LAMA (Tiotropium). If still uncontrolled: refer to pulmonologist for biologic therapy (anti-IgE, anti-IL-5). Oral steroids only as last resort for long-term control.

COPD: Diagnosis, Staging, and Management

Diagnosis

Suspect COPD in any patient >40 with: chronic productive cough, exertional breathlessness, or history of smoking / biomass fuel exposure (chulha cooking — a major Indian COPD cause, especially in women). Confirm with post-bronchodilator spirometry: FEV1/FVC <0.7.

GOLD Staging and Treatment

GOLD Stage FEV1 % Predicted Initial Treatment
GOLD 1 (Mild)≥80%SABA PRN + smoking cessation
GOLD 2 (Moderate)50–79%LAMA (Tiotropium 18mcg OD)
GOLD 3 (Severe)30–49%LAMA + LABA, consider ICS if frequent exacerbations
GOLD 4 (Very Severe)<30%Triple therapy (ICS+LABA+LAMA) + pulmonology co-management

All COPD patients regardless of stage: influenza vaccine annually, pneumococcal vaccine (PCV13 + PPSV23), pulmonary rehabilitation referral if available, smoking cessation counselling every visit.

Acute Exacerbation Management in OPD

AECOPD: acute worsening of respiratory symptoms beyond day-to-day variation. Decide: OPD treatment vs hospitalise?

Treat in OPD if all of: SpO₂ ≥92%, able to speak in full sentences, no accessory muscle use, no altered consciousness, good home support

Hospitalise immediately if any of: SpO₂ <90%, RR >30, HR >110, altered consciousness, inability to manage at home, failure to improve with initial treatment

OPD exacerbation protocol:

  1. Salbutamol 2.5mg nebulisation, repeat at 20 minutes if needed
  2. Ipratropium 500mcg nebulisation combined with salbutamol
  3. Prednisolone 40mg OD for 5 days
  4. Antibiotics if purulent sputum: Amoxicillin-clavulanate 625mg TDS or Doxycycline 100mg BD for 5 days
  5. Reassess SpO₂ 1 hour after nebulisation before discharge

Inhaler Technique: The Most Overlooked Treatment Failure

Studies show 70–80% of patients use inhalers incorrectly. Before escalating treatment, always assess technique:

pMDI (pressurised metered-dose inhaler) — common errors in India:

  • Not shaking before use
  • Inhaling too fast (should be slow, over 3–5 seconds)
  • Not holding breath for 10 seconds after inhalation
  • Firing the inhaler before starting to inhale

A spacer device eliminates most pMDI technique errors and is recommended for all patients, especially children and elderly. A 500ml plastic bottle with a hole cut in the cap works as a spacer in resource-limited settings.

TB Screening in OPD: Every Cough for 2 Weeks

India has 2.8 million new TB cases annually — 27% of the global burden. Every clinic doctor is on the front line of detection.

🫁
Universal TB screening in OPD
Every patient with cough ≥2 weeks: ask about fever, night sweats, weight loss. Sputum CBNAAT (GeneXpert) is the first-line test — more sensitive than smear microscopy and gives rifampicin resistance status simultaneously. CBNAAT is available free at government labs under NTEP. Order it, don't refer — you lose the patient in the referral chain.

TB treatment: Do not start treatment without microbiological confirmation if possible. Presumptive TB (CBNAAT negative but strong clinical suspicion): discuss with pulmonologist or DTCO. Nikshay portal: all diagnosed TB patients must be registered. Government provides free ATT (HRZE for 2 months, HR for 4 months) and monthly ₹500 nutritional support (Nikshay Poshan Yojana).

Community-Acquired Pneumonia in OPD

Use the CRB-65 score to decide OPD treatment vs admission:

  • Confusion: new onset
  • Respiratory rate ≥30/min
  • BP <90 systolic or <60 diastolic
  • Age ≥65

Score 0: OPD treatment. Score 1–2: Consider admission. Score ≥3: Hospitalise urgently.

OPD CAP treatment: Amoxicillin 500mg–1g TDS for 5 days (first choice). If atypical features (dry cough, bilateral infiltrates, younger patient): add Azithromycin 500mg OD for 3 days. Confirm improvement at 48 hours — failure to improve demands hospitalisation.

Keep respiratory patients on structured follow-up — SpO₂, symptom diary, inhaler reviews. Clinemo's appointment system helps schedule 3-month COPD reviews automatically →

Start Using Clinemo in Your Clinic Today

ABDM-ready · GST-compliant · Built for India · Free onboarding · 500+ clinics trust us

Tagged

COPD management clinic Indiaasthma OPD treatment Indiabreathlessness diagnosis Indian doctorsTB screening clinic Indiainhaler technique India